Corrigendum to “Evaluating change in diet with pegvaliase treatment in adults with phenylketonuria: Analysis of phase 3 clinical trial data” [Molecular Genetics and Metabolism 141, Issue 3 (2024) 108122] (Molecular Genetics and Metabolism (2024) 141(3), (S1096719223007527), (10.1016/j.ymgme.2023.108122))

The authors regret the following typographical errors within the published manuscript: SPR (sustained Phe response) in the following instances should instead state “blood Phe” (i.e. achievement of the noted threshold). Abstract The probability of achieving sustained Phe response (SPR) at ≤600 μmol/L was significantly greater for participants consuming medical protein versus no medical protein in an unadjusted analysis, but no statistically significant difference between groups was observed for probability of achieving SPR ≤360 or SPR ≤120 μmol/L. Materials and Methods, Section 2.4. Statistical analysis: Associations between achievement of SPR <360 μmol/L and baseline dietary pattern were assessed through time-to-event models. Results, Section 3.2.3. Diet and phe response: The probability of achieving SPR ≤600 μmol/L was significantly greater for participants consuming medical protein compared with those consuming no medical protein (Fig. 3). However, there was no statistically significant difference between the 3 baseline dietary groups for probability of achieving SPR ≤360 or SPR ≤120 μmol/L (Fig. 3). The authors would like to apologize for any inconvenience caused.